ClearPoint Neuro Announces FDA Clearance of the SmartFrame Array

$ 15.00

4.7
(365)
In stock
Description

Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint SmartFrame Array™ Version 1.1 SOLANA BEACH, Calif., April 28, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the brain, today announced that it has received FDA clearance for version 1.1 of its next generation SmartFrame Array Neuro Navi
Next Generation Neuro Navigation System Designed for Use in Both the MRI Suite and Operating Room ClearPoint SmartFrame Array™ Version 1.1 ClearPoint

Jacqueline Keller on LinkedIn: Two great pieces of news: 1) FDA clearance and FIH for our new 2.2…

ClearPoint Neuro, Inc. Announces First-in-Human Cases of the SmartFrame Array™ Neuro Navigation System and Software

ClearPoint Neuro (NasdaqCM:CLPT) Stock Forecast & Analyst Predictions - Simply Wall St

Neurosteer Announces FDA Clearance of the Neurosteer EEG Brain Monitoring Platform

Issue 17 - The Cancer Letter

Jacqueline Keller on LinkedIn: So proud of our teammates who applied over a decade of ClearPoint…

ClearPoint Neuro, Inc. on LinkedIn: #asgct22 #genetherapy #celltherapy #smartflow #clpt

ClearPoint Neuro (Nasdaq:CLPT) - Stock Price, News & Analysis - Simply Wall St

ClearPoint Neuro, Inc.: ClearPoint Neuro Reports Fourth Quarter and Full Year 2023 Preliminary Revenue Results and Guidance for Full Year 2024 Revenue